IL6 and cancer: These observations suggest the implication of SOX2 in sustaining inflammatory processes in aggressive tumors via FOSL2 and IL6. Tumors with high FOSL2 expression shared similar pathway activation as aggressive tumors, strongly implicating interconnection between FOSL2 and cancer aggressiveness.